SONOMA PHARMACEUTICALS, INC. Increase (Decrease) in Other Accounts Payable
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Increase (Decrease) in Other Accounts Payable of $216.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayable · last filed 2026-08-06
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for the quarter ending 2026-06-30 was $216.00K, a 78.95% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for the quarter ending 2026-03-31 was $282.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for the quarter ending 2025-12-31 was $229.00K, a 64.50% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for the quarter ending 2025-09-30 was -$666.00K, a 1900.00% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for fiscal 2026 was $871.00K, a 109.38% increase from fiscal 2025.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for fiscal 2025 was $416.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for fiscal 2024 was -$278.00K.
- SONOMA PHARMACEUTICALS, INC. increase (decrease) in other accounts payable for fiscal 2023 was -$864.00K.
| Period end | Increase (Decrease) in Other Accounts Payable 3 month | Increase (Decrease) in Other Accounts Payable 6 month | Increase (Decrease) in Other Accounts Payable 9 month | Increase (Decrease) in Other Accounts Payable 12 month |
|---|---|---|---|---|
| 2026-06-30 | $216.00K 10-Q · filed 2026-08-06 | $498.00K derived: sum of 2 quarters · filed 2026-08-06 | $727.00K derived: sum of 3 quarters · filed 2026-08-06 | $61.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $282.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $511.00K derived: sum of 2 quarters · filed 2026-06-16 | -$155.00K derived: sum of 3 quarters · filed 2026-06-16 | $871.00K 10-K · filed 2026-06-16 |
| 2025-12-31 | $229.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | -$437.00K derived: sum of 2 quarters · filed 2026-02-10 | $589.00K 10-Q · filed 2026-02-10 | $141.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-09-30 | -$666.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $360.00K 10-Q · filed 2025-11-04 | -$88.00K derived: sum of 3 quarters · filed 2026-08-06 | $557.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $1.03M 10-Q · filed 2026-08-06 | $578.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.22M derived: sum of 3 quarters · filed 2026-08-06 | $1.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$448.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-16 | $197.00K derived: sum of 2 quarters · filed 2026-06-16 | $234.00K derived: sum of 3 quarters · filed 2026-06-16 | $416.00K 10-K · filed 2026-06-16 |
| 2024-12-31 | $645.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-02-10 | $682.00K derived: sum of 2 quarters · filed 2026-02-10 | $864.00K 10-Q · filed 2026-02-10 | $598.00K derived: sum of 4 quarters · filed 2026-02-10 |
| 2024-09-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-11-04 | $219.00K 10-Q · filed 2025-11-04 | -$47.00K derived: sum of 3 quarters · filed 2025-11-04 | -$191.00K derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $182.00K 10-Q · filed 2025-08-07 | -$84.00K derived: sum of 2 quarters · filed 2025-08-07 | -$228.00K derived: sum of 3 quarters · filed 2025-08-07 | -$310.00K derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$266.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-06-17 | -$410.00K derived: sum of 2 quarters · filed 2025-06-17 | -$492.00K derived: sum of 3 quarters · filed 2025-06-17 | -$278.00K 10-K · filed 2025-06-17 |
| 2023-12-31 | -$144.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-02-05 | -$226.00K derived: sum of 2 quarters · filed 2025-02-05 | -$12.00K 10-Q · filed 2025-02-05 | -$523.00K derived: sum of 4 quarters · filed 2025-02-05 |
| 2023-09-30 | -$82.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-11-07 | $132.00K 10-Q · filed 2024-11-07 | -$379.00K derived: sum of 3 quarters · filed 2024-11-07 | -$174.00K derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $214.00K 10-Q · filed 2024-08-08 | -$297.00K derived: sum of 2 quarters · filed 2024-08-08 | -$92.00K derived: sum of 3 quarters · filed 2024-08-08 | -$1.07M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$511.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-06-17 | -$306.00K derived: sum of 2 quarters · filed 2024-06-17 | -$1.29M derived: sum of 3 quarters · filed 2024-06-17 | -$864.00K 10-K · filed 2024-06-17 |
| 2022-12-31 | $205.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-02-08 | -$776.00K derived: sum of 2 quarters · filed 2024-02-08 | -$353.00K 10-Q · filed 2024-02-08 | -$321.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | -$981.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-13 | -$558.00K 10-Q · filed 2023-11-13 | -$526.00K derived: sum of 3 quarters · filed 2023-11-13 | -$814.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $423.00K 10-Q · filed 2023-08-10 | $455.00K derived: sum of 2 quarters · filed 2023-08-10 | $167.00K derived: sum of 3 quarters · filed 2023-08-10 | $238.00K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-06-21 | -$256.00K derived: sum of 2 quarters · filed 2023-06-21 | -$185.00K derived: sum of 3 quarters · filed 2023-06-21 | -$157.00K 10-K · filed 2023-06-21 |
| 2021-12-31 | -$288.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-02-14 | -$217.00K derived: sum of 2 quarters · filed 2023-02-14 | -$189.00K 10-Q · filed 2023-02-14 | -$817.00K derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-09-30 | $71.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-11-14 | $99.00K 10-Q · filed 2022-11-14 | -$529.00K derived: sum of 3 quarters · filed 2022-11-14 | -$1.40M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $28.00K 10-Q · filed 2022-08-11 | -$600.00K derived: sum of 2 quarters · filed 2022-08-11 | -$1.47M derived: sum of 3 quarters · filed 2022-08-11 | -$2.43M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | -$628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-13 | -$1.50M derived: sum of 2 quarters · filed 2022-07-13 | -$2.46M derived: sum of 3 quarters · filed 2022-07-13 | -$796.00K 10-K · filed 2022-07-13 |
| 2020-12-31 | -$874.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-02-11 | -$1.83M derived: sum of 2 quarters · filed 2022-02-11 | -$168.00K 10-Q · filed 2022-02-11 | |
| 2020-09-30 | -$954.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-11-15 | $706.00K 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $1.66M 10-Q · filed 2021-08-16 | |||
| 2020-03-31 | $336.00K 10-K · filed 2021-07-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |